MediPharm Labs (LABS) Competitors C$0.07 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines LABS vs. HLS, TGOD, NINE, WMD, MDP, SUGR, VIR, ZOM, IN, and METAShould you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include HLS Therapeutics (HLS), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), WeedMD (WMD), Medexus Pharmaceuticals (MDP), SugarBud Craft Growers (SUGR), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), InMed Pharmaceuticals (IN), and Meta Growth (META). These companies are all part of the "drug manufacturers - specialty & generic" industry. MediPharm Labs vs. HLS Therapeutics Green Organic Dutchman Delta 9 Cannabis WeedMD Medexus Pharmaceuticals SugarBud Craft Growers Viridium Pacific Group Zomedica Pharmaceuticals Corp. (ZOM.V) InMed Pharmaceuticals Meta Growth HLS Therapeutics (TSE:HLS) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, community ranking, earnings, profitability, valuation and analyst recommendations. Do analysts prefer HLS or LABS? HLS Therapeutics presently has a consensus price target of C$3.63, indicating a potential upside of 11.54%. Given HLS Therapeutics' higher probable upside, analysts plainly believe HLS Therapeutics is more favorable than MediPharm Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HLS Therapeutics 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33MediPharm Labs 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the media favor HLS or LABS? In the previous week, HLS Therapeutics had 1 more articles in the media than MediPharm Labs. MarketBeat recorded 1 mentions for HLS Therapeutics and 0 mentions for MediPharm Labs. HLS Therapeutics' average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score. Company Overall Sentiment HLS Therapeutics Neutral MediPharm Labs Neutral Does the MarketBeat Community prefer HLS or LABS? HLS Therapeutics received 9 more outperform votes than MediPharm Labs when rated by MarketBeat users. Likewise, 66.67% of users gave HLS Therapeutics an outperform vote while only 65.79% of users gave MediPharm Labs an outperform vote. CompanyUnderperformOutperformHLS TherapeuticsOutperform Votes3466.67% Underperform Votes1733.33% MediPharm LabsOutperform Votes2565.79% Underperform Votes1334.21% Do institutionals and insiders hold more shares of HLS or LABS? 65.2% of HLS Therapeutics shares are owned by institutional investors. Comparatively, 0.7% of MediPharm Labs shares are owned by institutional investors. 0.4% of HLS Therapeutics shares are owned by insiders. Comparatively, 4.5% of MediPharm Labs shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is HLS or LABS more profitable? MediPharm Labs has a net margin of -35.25% compared to HLS Therapeutics' net margin of -40.90%. HLS Therapeutics' return on equity of -24.82% beat MediPharm Labs' return on equity.Company Net Margins Return on Equity Return on Assets HLS Therapeutics-40.90% -24.82% -2.89% MediPharm Labs -35.25%-24.96%-7.17% Which has higher valuation and earnings, HLS or LABS? MediPharm Labs has lower revenue, but higher earnings than HLS Therapeutics. HLS Therapeutics is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHLS TherapeuticsC$58.89M1.75-C$24.09M-C$1.01-3.22MediPharm LabsC$37.76M0.76-C$13.31M-C$0.04-1.75 Which has more risk and volatility, HLS or LABS? HLS Therapeutics has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. Comparatively, MediPharm Labs has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. SummaryHLS Therapeutics beats MediPharm Labs on 11 of the 16 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart LABS vs. The Competition Export to ExcelMetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$28.78MC$1.22BC$5.54BC$5.94BDividend YieldN/A3.13%5.13%5.37%P/E Ratio-1.75110.69114.8125.89Price / Sales0.763,426.271,495.551,515.70Price / Cash1.3010.1939.6781.06Price / Book0.583.174.663.11Net Income-C$13.31MC$155.16MC$119.06MC$292.76M7 Day PerformanceN/A-0.02%0.80%-1.67%1 Month PerformanceN/A-0.71%5.65%2.31%1 Year PerformanceN/A100.92%36.75%45.72% MediPharm Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSMediPharm LabsN/AC$0.07flatN/A+0.0%C$28.78MC$37.76M-1.75130Gap UpHLSHLS Therapeutics1.3745 of 5 starsC$3.51-8.6%C$3.63+3.3%-34.1%C$111.58MC$58.89M-3.4891Upcoming EarningsNews CoverageTGODGreen Organic DutchmanN/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap UpHigh Trading VolumeNINEDelta 9 CannabisN/AC$1.03+3.0%N/A+0.0%C$89.36MC$12.87M19.07940Gap UpWMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpMDPMedexus Pharmaceuticals2.3251 of 5 starsC$2.56-1.2%C$5.88+129.5%+20.3%C$62.80MC$108.78M51.2098Upcoming EarningsNews CoverageSUGRSugarBud Craft GrowersN/AC$8.75-4.9%N/A+7,990.9%C$59.68MC$575.64M10.5444News CoverageGap DownVIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap UpZOMZomedica Pharmaceuticals Corp. (ZOM.V)N/AC$0.29-6.6%N/A+0.0%C$36.73MN/A-2.6150Gap DownINInMed PharmaceuticalsN/AN/AN/AN/AC$33.73MC$574,677.00-2.7712METAMeta GrowthN/AC$0.14flatN/A+0.0%C$33.14MC$60.96M-0.6686,500News CoverageGap Down Related Companies and Tools Related Companies HLS Therapeutics Competitors Green Organic Dutchman Competitors Delta 9 Cannabis Competitors WeedMD Competitors Medexus Pharmaceuticals Competitors SugarBud Craft Growers Competitors Viridium Pacific Group Competitors Zomedica Pharmaceuticals Corp. (ZOM.V) Competitors InMed Pharmaceuticals Competitors Meta Growth Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:LABS) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
